Search clinical trials for: Inj. Octreotide

Total 11357 results

PVS Memorial Hospital

Completed

Role of Octreotide in Preventing Pancreatic Fistula After Pancreaticoduodenectomy (PD) in Patients With Soft Pancreas (PD)

Pancreatic Fistula

India
Advanced Accelerator Applications

Completed

A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours (NETTER-1)

Carcinoid Tumor of the Small Bowel | Neuroendocrine Tumour

United States, United Kingdom, Italy, Belgium, France, Germany, Portugal, Spain
Sinotau Pharmaceutical Group

Recruiting

A Study Comparing Treatment With Lutetium[177Lu] Oxodotreotide Injection to Octreotide LAR in Patients With GEP-NETs

Neuroendocrine Tumors

China
Novartis

Completed

Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy

Diabetic Retinopathy

United States
St. Josef Hospital Bochum

Completed

Effects of Intraarterial Octreotide on Pancreatic Texture

Pancreatic Fistula

Germany
Novartis Pharmaceuticals

Terminated

Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy

Diabetic Retinopathy
Novartis Pharmaceuticals

Terminated

Extension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy

Diabetic Retinopathy
Novartis Pharmaceuticals

Completed

Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly

Acromegaly

Germany
Novartis

Completed

Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy

Diabetic Retinopathy

United States
AdventHealth

Terminated

Prophylactic Octreotide to Prevent Post Duodenal EMR and Ampullectomy Bleeding

Adenoma

United States
Aspireo Pharmaceuticals Limited

Completed

Multiple Ascending Dose Tolerability, Pharmacokinetic and Pharmacodynamic Study of DG3173

Healthy
Mayo Clinic

Completed

Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis

Cirrhosis | Portal Hypertension | Esophageal Varices
Chengfeng Wang

Unknown

The Effect of Preoperative Long Period Octreotide Combined With Postoperative Short Period Octreotide on the Complications After Pancreatectomy. A Prospective, Multicenter Clinical Trial

Pancreatic Diseases

China
Novartis Pharmaceuticals

Completed

Evaluation of Octreotide LAR in Prevention of Chemotherapy-induced Diarrhea (LARCID)

Chemotherapy-induced Diarrhea

Brazil
Qilu Pharmaceutical Co., Ltd.

Completed

Bioequivalence Study of Two Octreotide Microsphere Formulations in Healthy Volunteers

Healthy Volunteers

China
Peking University

Unknown

Octreotide LAR as Maintenance Treatment for Patients With NEC

Esophageal Neuroendocrine Carcinoma | Gastro-entero-pancreatic Carcinoma

China
Qilu Hospital of Shandong University

Not yet recruiting

A Real-world Study of Octreotide Microspheres in Chinese Patients With Neuroendocrine Tumors

Neuroendocrine Tumors

China
Azidus Brasil

Suspended

Pharmacodynamics Of Product Octreotide Acetate Lar 30 Mg Compared To Product Sandostatin LAR ®

Acromegaly

Brazil
Cliniques universitaires Saint-Luc- Université...

Terminated

Sandostatin (Octreotide LAR) May Lead to Clinical Improvement Through Receptor Occupation Optimisation (SCIROCCO)

Neuroendocrine Tumors | Carcinoid Syndrome
Endo Pharmaceuticals

Completed

Open Label Study of Octreotide Implant in Patients With Acromegaly

Acromegaly
Novartis

Completed

Effects of Octreotide Acetate on Circulating Levels of Chromogranin A in Advanced Prostate Cancer Patients

Prostate Cancer

Italy
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Terminated

Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors

Head and Neck Cancer | Metastatic Cancer | Pheochromocytoma | Islet Cell Tumor

United States
Institut National de la Santé Et de la Recherche...

Completed

Treatment of Idiopathic Pulmonary Fibrosis With Long Acting Octreotide (FIBROSAND)

Idiopathic Pulmonary Fibrosis
National Center for Research Resources (NCRR)
Yale University

Completed

Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for Gastrointestinal Hemorrhage in Hormone-Refractory Hereditary Hemorrhagic Telangiectasia and Senile Ectasia

Hereditary Hemorrhagic Telangiectasia | Ectasia
Duke University

Completed

Effect of Octreotide on Saliva

Healthy

United States
University Hospital, Rouen

Completed

Somatostatin Analog Treatment of Acromegaly Before Pituitary Surgery : Comparison With Neurosurgery Alone (SAPORO)

Acromegaly

France
Aspireo Pharmaceuticals Limited

Completed

Single Dose Pharmacology Study of DG3173 and Octreotide in Acromegalic Patients.

Acromegaly
Mario Negri Institute for Pharmacological Research

Recruiting

Outcome of ADPKD With Octreotide LAR (ADPKD648)

Autosomal Dominant Polycystic Kidney

Italy
Fredrik Klevebro
Karolinska University Hospital

Recruiting

Octreotide Treatment to Improve Nutritional Recovery After Surgery for Patients With Esophageal or Gastric Cancer (OTIS)

Gastric Cancer | Esophageal Cancer

Sweden
Novartis Pharmaceuticals

Completed

Open Label Study of a Single Dose of a New Extended Long Acting Formulation of Octreotide Pamoate in Healthy Volunteers

Healthy Cholecystectomized

France, Italy, Belgium
Novartis

Completed

Safety and Efficacy of Octreotide Long Acting Release (LAR) in Treatment Naïve Acromegalic Patients

Acromegaly
Federico II University

Completed

Dose Escalation of Octreotide-LAR as First-Line Therapy in Resistant Acromegaly (HDacro)

Acromegaly

Italy
National Hepatology & Tropical Medicine Research...

Recruiting

Role of Octreotide in Non Variceal Bleeding

Non-variceal Gastrointestinal Bleeding

Egypt
Aspireo Pharmaceuticals Limited

Completed

The Effect of Subcutaneous Infusions of 3 Doses of DG3173 on Growth Hormone Levels in Untreated Acromegalics

Acromegaly
Novartis Pharmaceuticals

Terminated

Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With Acromegaly, With Micro or Macroadenomas

Acromegaly

Mexico
Novartis Pharmaceuticals

Completed

Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs. Surgery in Treatment-naïve Patients With Acromegaly

Acromegaly
Beijing Children's Hospital

Completed

Efficacy and Safety Evaluation of Octreotide in the Treatment of Congenital Hyperinsulinemia (BCH)

Congenital Hyperinsulinaemic Hypoglycaemia | Octreotide Adverse Reaction

China
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Octreotide in Treating Patients With Cancer-Related Malignant Ascites

Unspecified Adult Solid Tumor, Protocol Specific | Metastatic Cancer

United States
Virginia Commonwealth University
Novartis; Thoratec Corporation

Completed

Safety Study of Octreotide Injection to Prevent GI Bleeding in Patients With Left Ventricular Assist Device (LVAD)

Gastrointestinal Bleeding

United States
Chiasma, Inc.

Unknown

Efficacy and Safety of Octreotide Capsules (MYCAPSSA) in Acromegaly (OPTIMAL)

Acromegaly

United States, Israel, Canada, Denmark, Netherlands, New Zealand, Australia, United Kingdom, Hungary, Italy, Poland, Bulgaria, Germany, Latvia, Slovenia, Sweden, Turkey
Northwestern University
National Cancer Institute (NCI)

Completed

Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery

Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Small Intestine Cancer | Ovarian Cancer | Peritoneal Cavity Cancer | Gastrointestinal Stromal Tumor | Extrahepatic Bile Duct Cancer | Nausea and Vomiting | Constipation, Impaction, and Bowel Obstruction

United States
Radiomedix, Inc.
Orano Med LLC

Active, not recruiting

Targeted Alpha-emitter Therapy of PRRT Naïve and Previous PRRT Neuroendocrine Tumor Patients (ALPHAMEDIX02)

Neuroendocrine Tumors

United States
University College, London
National Institute for Health Research, United Kingdom

Active, not recruiting

A Feasibility Study of Octreotide Infusion During Liver Transplant. (Octreotide)

Liver Transplantation | Renal Failure

United Kingdom
Rigshospitalet, Denmark
University of Aarhus; Bispebjerg Hospital

Completed

Octreotide Improves Human Lymphatic Fluid Transport a Translational Trial

Lymphatic Diseases | Chylothorax

Denmark
Centre Hospitalier Universitaire, Amiens

Withdrawn

Macro and Microcirculatory Effects of the Combination of Norepinephrine and Octreotide for the Treatment of Cirrhotic Patients With Hemorrhagic Shock (HemodyNoOc)

Variceal Hemorrhage | Haemorrhagic Shock

France
Lexicon Pharmaceuticals

Completed

Phase 1, Open-label, Drug-drug Interaction Study With Octreotide Acetate Injection and Telotristat Etiprate in Healthy Subjects

Drug Interactions

United States
NYU Langone Health

Completed

Surgical Debulking of Pituitary Adenomas

Pituitary Adenoma

United States
Radiation Therapy Oncology Group
National Cancer Institute (NCI)

Completed

Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer

Colorectal Cancer | Anal Cancer | Drug/Agent Toxicity by Tissue/Organ | Radiation Enteritis

United States
Radiomedix, Inc.
Orano Med LLC

Recruiting

Phase 1 Study of AlphaMedix™ in Adult Subjects With SSTR (+) NET

Neuroendocrine Tumor

United States
Changhai Hospital

Completed

Real-world Study on Adjuvant Octreotide Therapy in pNETs

Pancreatic Neuroendocrine Tumor G2

3

Subscribe